成本—效果分析越来越多地作为卫生政策的依据。许多这样的分析常把昂贵的医疗手段与高成本效率的规划(如高血压筛选)作比较,说明如果减少前者使用的资源,用于后者,那么,卫生服务的效率将得以改善。但是,实际上用这种办法未必能节省。我们 Cost-effectiveness analysis is increasingly used as a basis for health policy. Many of these analyses often compare expensive medical treatment with cost-effective planning (eg, screening for hypertension), indicating that if the former uses less resources for the latter, then the efficiency of health services will improve. However, in practice this approach may not be able to save. we